Jump to section
Woebot's mission is to create new ways to deliver mental health care, so people can access effective support at any moment.
19% employee growth in 12 months
With the mental health crisis only exacerbated by the events of recent years, and clinical care struggling to work through the backlog, many US citizens are not receiving the critical care they need to manage their mental health. Woebot is a tech startup looking to address this issue, with an AI chatbot designed to provide 24/7 front-line mental health support to its users.
The company has received plenty of column inches and strong financial backing. Importantly, however, it is getting the clinical thumbs up too: Woebot received the FDA’s breakthrough device designation for its use in post partum depression cases. This step has only been completed by other apps for separate mental health issues such as Vorvida for problem drinking and Pear Therapeutics for opioid abuse.
The use of digital therapeutics is expected to begin gaining real momentum over coming years, as the need for clinical support increases and the complexity and efficacy of mental healthtech develops. Funding has, consequently, spiked for healthcare bots, and Woebot has been a major beneficiary, but if the market proves as hot as anticipated, it may have to watch its back against smaller competitors like Wysa, Youper, and X2.
Steph
Company Specialist at Welcome to the Jungle
Mar 2022
$9.5m
LATE VC
Jul 2021
$90m
SERIES B
This company has top investors
Alison Darcy
(Founder & President)A Psychologist and healthcare designer with over 20 years experience building health tech. Gained her PhD at Stanford University School of Medicine, before working as a Senior Investigator and returning to Stanford as an Instructor.